Phibro Animal Health Corporation Financial Results Fiscal Year 2022 Second Quarter Ended December 31, 2021 Webcast and Conference Call February 10, 2022 U.S. toll-free +1-888-330-2022 International toll +1-365-977-0051 Conference ID: 3927884 February 10, 2022 Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statement ...

Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2022 Earnings Conference Call February 10, 2022 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President & Chief Executive Officer Daniel Bendheim - Director & Executive Vice President of Corporate Strategy Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - Bank of America Operator Good morning. My name is Shantel and I'll be your conference operator today. At this time, I would like t ...

Table of Contents Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 13-1840497 (State or other jurisdiction of (I.R.S. Employer UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tra ...

Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2022 Earnings Conference Call November 3, 2021 9:00 AM ET Company Participants Damian Finio - CFO Jack Bendheim - Chairman, President and CEO Daniel Bendheim - Director and EVP, Corporate Strategy Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - Bank of America David Westenberg - Guggenheim Securities Operator Good morning. My name is Shantel, and I will be your conference operator today. At this time, I would like to welcome everyo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 Phibro Animal Health Corporation (Exact name of registrant as specified in its charter) Delaware 13 ...

Phibro Animal Health Corporation (NASDAQ:PAHC) Q4 2021 Earnings Conference Call August 26, 2021 9:00 AM ET Company Participants Damian Finio - CFO Jack Bendheim - Chairman, President and CEO Donny Bendheim - Director and EVP, Corporate Strategy Conference Call Participants Katie Tryhane - Credit Suisse Michael Ryskin - Bank of America Operator Thank you for standing by and welcome to the Phibro Animal Health Corporation Q4 2020 (sic) [2021] Conference Call. At this time, all participants are in a listen-onl ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36410 | Class A Common Stock, $0.0001 | | | | --- | --- | --- | | Title of each class par value per share | Trading Sy ...

Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2021 Earnings Conference Call May 7, 2021 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President & Chief Executive Officer Donny Bendheim - Director & Executive Vice President of Corporate Strategy Conference Call Participants David Westenberg - Guggenheim Securities Erin Wright - Credit Suisse Michael Ryskin - Bank of America Kevin Kedra - G. Research Operator Good day and thank you for standing by. Welco ...

Phibro Animal Health Corporation Financial Results Third Quarter - ended March 31, 2021 Fiscal Year 2021 Webcast and Conference Call May 7, 2021 U.S. toll-free +1-833-968-1955 International toll +1-647-689-6656 Conference ID: 2181337 Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________to______ Commission File Number: 001-36410 Phibro Animal Health Corporation incorporation or organization) Identification No.) Glenp ...